  The use of drugs or radiation to attack cancerous cells often leaves the
treatment material within the body where it could affect healthy cells or
damages healthy tissue; as is the case with traditional invasive surgery. An
alternative approach is the creation of a nano machine that is directed to its
target (the cancerous tissue), then activated to engage cancerous cells and
"surgically" induce controlled apoptosis. A magneto-mechanical device composed
of nanomagnets that potentially meets this objective is thus predicated. The
magnetic particles must be bio-functionalised for "in-body" use where their
uniqueness allows precise tracking and manipulation. In order to
bio-functionalize magnetic particles they have to be embedded in a
biocompatible coating or shell. Even enclosed within a biological entity the
application of magnetic field gradients result in significant forces acting
upon the magnetic particles. As such, single domain, ferromagnetic particles
can be used inside the body for a number of applications. The lack of naturally
occurring ferromagnetic particles inside the human body allows the
bio-functionalized particles to be detectable, without the interference of
noise from the host environment. Therefore, it is of paramount importance, for
medical applications, to understand exactly how the magnetic particles will
respond to a magnetic field gradient. Accordingly, the magnetic response of a
system of four interacting magnetic particles is examined and it is shown that
such a system can be optimised for targeting cancer cells and performing
nano-surgical operations. The range of magnetic field required for such
nano-medical applications is specified and the connection of these applications
to different phase transitions arising in the magnetic field is described.
